Retatrutide is a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors, enhancing glucose metabolism, reducing appetite, and promoting energy expenditure. It is being studied for its role in metabolic health, particularly in the context of obesity and weight management.